ST. LUKES JEROME LTD — History
CCN 131310 | 3-year financial timeline | COVID resilience: 76/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
+9.4%
Revenue CAGR (3yr)
-2.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $17M | $20M | $20M | -1.5% | +9.4% |
| Operating Expenses | $20M | $20M | $20M | +0.1% | -0.2% |
| Operating Margin | -22.8% | -0.6% | -2.2% | -279.8% | +0.0% |
| Net Income | $-4M | $-0M | $-0M | -274.3% | +0.0% |
| Licensed Beds | 18 | 18 | 17 | -5.6% | -2.8% |
| Total Patient Days | 2,435 | 2,531 | 2,510 | -0.8% | +1.5% |
| Medicare Day % | 31% | 40% | 47% | +16.0% | +23.7% |
| Medicaid Day % | 25% | 27% | 19% | -27.4% | -12.7% |
COVID Impact & Recovery
Resilience Score: 76/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +19.7% ($17M → $20M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+9.4%
This Hospital
+7.6%
State Avg
Latest Margin
-2.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $22M | 8.1% |
| FY2024 (proj) | $23M | 18.4% |
| FY2025 (proj) | $25M | 28.7% |